Carevive SMART Data – EVALUATE

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly, the invaluable trends that longitudinal real-world data sets can reveal about the patient experience. Lastly, how digital tools empower clinicians to predict and manage the experiences of cancer patients more effectively.

With a comprehensive approach, Carevive is transforming cancer care by harnessing the power of patient experience insights. Join us on this transformative journey as we continue to make a positive impact on the lives of cancer patients and their healthcare providers. Together, we build a brighter future for cancer care, one step at a time.

Recent Episodes

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…

As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare…